Bioextrax AB (publ) (STO:BIOEX)

Bioextrax AB Statistics

Total Valuation

Bioextrax AB has a market cap or net worth of SEK 140.31 million. The enterprise value is 136.38 million.

Market Cap	140.31M
Enterprise Value	136.38M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Bioextrax AB has 46.31 million shares outstanding. The number of shares has increased by 18.85% in one year.

Current Share Class	46.31M
Shares Outstanding	46.31M
Shares Change (YoY)	+18.85%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	17.62%
Owned by Institutions (%)	15.99%
Float	37.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	107.19
PB Ratio	6.61
P/TBV Ratio	6.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.70
EV / Sales	104.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.21

Financial Position

The company has a current ratio of 1.58

Current Ratio	1.58
Quick Ratio	1.28
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17,839.00

Financial Efficiency

Return on equity (ROE) is -74.90% and return on invested capital (ROIC) is -47.17%.

Return on Equity (ROE)	-74.90%
Return on Assets (ROA)	-41.51%
Return on Invested Capital (ROIC)	-47.17%
Return on Capital Employed (ROCE)	-84.09%
Weighted Average Cost of Capital (WACC)	13.80%
Revenue Per Employee	93,500
Profits Per Employee	-1.26M
Employee Count	14
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.67% in the last 52 weeks. The beta is 1.74, so Bioextrax AB's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	+13.67%
50-Day Moving Average	2.41
200-Day Moving Average	2.83
Relative Strength Index (RSI)	63.68
Average Volume (20 Days)	107,295

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioextrax AB had revenue of SEK 1.31 million and -17.71 million in losses. Loss per share was -0.45.

Revenue	1.31M
Gross Profit	51,000
Operating Income	-17.84M
Pretax Income	-17.71M
Net Income	-17.71M
EBITDA	-16.71M
EBIT	-17.84M
Loss Per Share	-0.45

Balance Sheet

The company has 3.93 million in cash and n/a in debt, with a net cash position of 3.93 million or 0.08 per share.

Cash & Cash Equivalents	3.93M
Total Debt	n/a
Net Cash	3.93M
Net Cash Per Share	0.08
Equity (Book Value)	21.22M
Book Value Per Share	0.53
Working Capital	2.03M

Cash Flow

In the last 12 months, operating cash flow was -26.05 million and capital expenditures -152,000, giving a free cash flow of -26.20 million.

Operating Cash Flow	-26.05M
Capital Expenditures	-152,000
Free Cash Flow	-26.20M
FCF Per Share	-0.57

Margins

Gross Margin	3.90%
Operating Margin	-1,362.80%
Pretax Margin	-1,352.56%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bioextrax AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.85%
Shareholder Yield	-18.85%
Earnings Yield	-12.62%
FCF Yield	-18.67%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 22, 2021. It was a forward split with a ratio of 4.

Last Split Date	Jul 22, 2021
Split Type	Forward
Split Ratio	4

Scores

Bioextrax AB has an Altman Z-Score of 17.01 and a Piotroski F-Score of 2.

Altman Z-Score	17.01
Piotroski F-Score	2